Co-amplification frequency quickly dropped downstream of e4, suggesting that MYCN-specific, CRC-driven enhancers are a determinant of MYCN amplicon structure and may be required for MYCN expression, even in the context of high-level amplification. This evidence concerns the gene MYCN and colorectal carcinoma.